Blood test may predict Behçet's flare-ups
NCT ID NCT06729112
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a new blood test called the pan-immune-inflammation value (PIN) can help measure disease activity in people with Behçet's syndrome. Researchers compared 80 Behçet's patients to healthy controls. The goal is to find a simple, non-invasive way to monitor this complex inflammatory disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide doctors with a simple blood test to help monitor Behçet's disease activity and guide treatment decisions.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The PIN value needs much larger validation before it could be used in routine care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHCET SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University Hospitals
Asyut, 71111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New protein clue may help track Behcet's disease activity
- Landmark study questions blood thinner use in Behçet's clots
- Behçet's disease: hidden mental toll revealed in new study
- New study aims to uncover hidden health impacts of rare blood vessel diseases
- New pill shows promise for rare inflammatory disease
- New hope for Behcet's patients: drug TA-650 targets tough lesions